ABCDEFGHIJKLMNOPQRSTUVWXYZ
1
Deal DateR&DClientUpfront Cash ($M)Deal Size ($M)Deal SubjectDeal TypesExclusivityStageHas TagsDocument SourceDiseaseIndicationTechnologySub-TechnologyTerritorySub-Territory
2
6/2015University of California, UC DavisSage Therapeutics$0.110$2.800Allopregnanolone (neurosteroid) for use in seizures and traumatic brain injuryLicenseExclusivePreclinicalYesSEC RedactedCentral Nervous SystemOther Central Nervous System, Spinal Cord InjuryWorldwide
3
6/2015University of Jerusalem, Yissum Research DevelopmentImmune Pharmaceuticals$0.030$4.930Topical nano-formulation of AmiKet for painLicense, ResearchExclusiveFormulationYesSEC FullCentral Nervous SystemPainDrug Delivery, SyntheticsSmall Molecule, TopicalWorldwide
4
6/2015University of South FloridaCellular Biomedicine$2.500$29.300CD40LGVAX vaccine and related technologies for lung cancerLicenseExclusivePhase IPress ReleaseCancerLungVaccinesWorldwide
5
1/2015San Raffaele Telethon Institute For Gene TherapyBiogen$5.000Lentiviral gene transfer technology to develop gene therapies for hemophiliaLicense, Option, ResearchDiscoveryPress ReleaseHematologicHemophiliaOligonucleotidesGene TherapyWorldwide
6
12/2014Scripps Research InstituteCorvus$0.110$2.700Mouse CD73 antibody for treatment of cancerLicenseNon-exclusiveLead MoleculeYesSEC RedactedCancerBroad Focus CancerMonoclonalsWorldwide
7
12/2014Tufts UniversityTracon Pharmaceuticals$0.150$7.950TRC205 ( humanized anti-endoglin antibody) in cardiac fibrosisLicense, Option, ResearchExclusivePreclinicalSEC RedactedCardiovascularOther CardiovascularMonoclonalsHumanized AbsWorldwide
8
11/2014BaylorBellicum Pharmaceuticals$0.025$0.300Methods for Inducing Selective ApoptosisLicenseExclusiveDiscoveryYesSEC RedactedCancerBroad Focus CancerCell Therapy - Stem Cells/FactorsWorldwide
9
6/2014Dartmouth CollegeCelyad, Celdara Medical$0.030$1.630Anti-B7-H6 ImmunotherapiesDevelopment, LicenseExclusiveYesSEC FullCancerWorldwide
10
6/2014University of IllinoisCortex Pharmaceuticals$0.475$2.400IP related to use of cannabinoids for sleep related breathing disordersLicenseExclusiveLead MoleculeYesSEC FullCentral Nervous SystemSleep DisordersSyntheticsSmall MoleculeWorldwide
11
3/2014University of MiamiHeat Biologics$0.015$0.020Recombinant gp120 protein vaccination for protection from SIV/HIVDevelopment, LicenseExclusivePreclinicalYesSEC RedactedInfectious-ViralHuman Immunodeficiency Virus/HIV, Other Infectious-ViralVaccinesWorldwide
12
11/2013Memorial Sloan KetteringJuno Therapeutics$6.900$150.000JCAR015 (CD19 CAR-T) for immunotherapy of solid tumors & CRO servicesEquity, License, Research, ServicesExclusivePhase IYesSEC RedactedCancerCell Therapy - Stem Cells/FactorsWorldwide
13
10/2013Ohio State University, Nationwide Childrens HospitalAveXis$0.100$0.230AVXS-101 (human SMN gene) for spinal muscular atrophy (SMA) Type 1Equity, License, ResearchExclusivePreclinicalSEC RedactedOther/MiscellaneousGenetic DisordersOligonucleotidesGene TherapyWorldwide
14
5/2013StanfordFate Therapeutics$0.040Wnt proteins for stem cell modulationEquity, LicenseExclusiveDiscoveryYesSEC RedactedHematologic, TransplantationBroad Focus Hematologic, Broad Focus TransplantationCell Therapy - Stem Cells/FactorsWorldwide
15
3/2013University of ColoradoSyndax Pharmaceuticals$0.200license and option for novel therapeuticsDevelopment, License, OptionExclusivePhase IYesSEC RedactedWorldwide
16
1/2013YaleBind Therapeutics$0.025Targeted and high density drug-loaded polymeric materials for treatment of cancerLicenseExclusiveDiscoveryYesSEC RedactedCancerBroad Focus CancerSyntheticsSmall MoleculeWorldwide
17
9/2012Baylor Research InstituteUltragenyx Pharmaceutical$0.250Tripheptanoin (UX007) for long-chain fatty acid oxidation disordersDevelopment, License, OptionExclusivePhase IIYesSEC RedactedEndocrinological & MetabolicOther Endocrinological & MetabolicSyntheticsSmall MoleculeWorldwide
18
7/2012Dartmouth CollegeChromaDex$0.085$0.090IP covering pharmaceutical use of nicotinamide ribosideDevelopment, LicenseExclusiveYesFOIAOther/MiscellaneousNutritionals/VitaminsNatural ProductWorldwide
19
6/2012Scripps Research InstituteCempra$0.585$1.690Solithromycin macrolides for antibiotic resistance ex-ASEANLicenseExclusiveLead MoleculeYesSEC RedactedInfectious-BacterialBroad Focus Infectious-BacterialSyntheticsCombinatorialAfrica, Asia, Europe, Middle East, NAFTA, South AmericaAll African Countries, All European Countries, All Middle East Countries, All NAFTA Countries, All South American Countries, Australia, China, India, Japan, New Zealand, Other Asian
20
5/2012Mass General HospitalProQR Therapeutics$0.010$0.010novel therapeutics for treatment of cystic fibrosisDevelopment, LicenseExclusivePreclinicalYesSEC RedactedRespiratoryCystic FibrosisWorldwide
21
4/2012University of California, UC San FranciscoPhotoMedex$0.030$0.030treatment of psoriasis and other inflammatory skin diseaseDevelopment, LicenseExclusiveYesSEC FullDermatologicOther Dermatologic, PsoriasisWorldwide
22
3/2012YaleMedistem$0.045$1.150Endometrial derived stem cells to treat diabetesDevelopment, LicenseExclusivePreclinicalYesSEC FullEndocrinological & MetabolicDiabetesCell Therapy - Stem Cells/FactorsWorldwide
23
1/2012NIHKineMed$0.290$18.0405a peptide for cardio vascular diseasesLicenseExclusivePreclinicalYesSEC FullCardiovascularAngina, Atherosclerosis/Coronary Artery Disease, Congestive Heart Failure, Myocardial Infarction, Other Cardiovascular, Peripheral Arterial DiseasePeptidesWorldwide
24
12/2011Texas A&MOragenics$0.005$0.710Site directed mutagenesis of Mutacin 1140Development, LicenseExclusivePreclinicalYesSEC FullPeptidesWorldwide
25
8/2011NIHuniQure$0.155$0.160AAV5 based therapeutics for brain and liver diseasesDevelopment, LicenseExclusivePreclinicalYesSEC RedactedOther/MiscellaneousOligonucleotidesGene TherapyWorldwide
26
8/2011StanfordImmuMetrix$0.040$0.040non-invasive diagnosis of graft rejection in organ transplantEquity, License, ResearchExclusiveDiagnostic, DeviceYesSEC RedactedTransplantationOrgan/Tissue TransplantsDiagnosticsWorldwide
27
7/2011University of MichiganHeat Biologics$0.060$0.810blander cancer cell linesDevelopment, LicenseExclusivePreclinicalYesSEC FullCancerBladderWorldwide
28
4/2011University of California, UC San Diego, Dana-FarberAdamis Pharmaceuticals$0.060$1.920telomerase reverse transcription antigen for immunization in cancerDevelopment, LicenseExclusivePhase IYesSEC FullCancerBroad Focus CancerVaccinesNAFTAUS
29
4/2011University of CincinnatiARCA Biopharma$0.030$0.030Patents covering genetic polymorphisms of adrenergic cardiac receptors for companion diagnosticLicenseDiagnosticYesSEC RedactedCardiovascularCongestive Heart FailureDiagnosticsWorldwide
30
4/2011Yissum Research DevelopmentImmune Pharmaceuticals$0.030$15.480Antibody nanoparticle conjugates for the targeted delivery_x000D_
of active agents conjugated to antibodie		Development, License, ResearchExclusivePreclinicalYesSEC FullDrug Delivery, MonoclonalsHuman AbsWorldwide
31
3/2011Cornell UniversityStrongbridge Biopharma$0.439$3.010Commensal bacteria as signal mediatorsDevelopment, LicenseExclusivePreclinicalYesSEC FullWorldwide
32
3/2011New York UniversityRegulus Therapeutics$0.025novel therapeutics for microRNA 33, metabolic disorders, and atherosclerosisLicenseExclusiveYesSEC RedactedCardiovascular, Endocrinological & MetabolicAtherosclerosis/Coronary Artery DiseaseWorldwide
33
2/2011University of MiamiHeat Biologics$0.010$0.010Vaccine for treatment of nonsmall cell lung cancerLicenseExclusiveYesSEC RedactedCancerLungVaccinesWorldwide
34
2/2011University of MichiganMedgenics$0.075$3.230gene therapy productsLicenseExclusivePreclinicalYesSEC FullOligonucleotidesGene TherapyWorldwide
35
12/2010Weizmann InstituteProlor Biotech$0.025$0.030Long·acting Cytokine pharmaceuticalsDevelopment, LicenseExclusiveYesFOIAWorldwide
36
10/2010San Raffaele Telethon Institute For Gene TherapyGlaxoSmithKline$14.000Ex vivo gene therapy for adenosine deaminase severe combined immunodeficiency syndromeDevelopment, License, OptionExclusivePhase IPress ReleaseOther/MiscellaneousGenetic DisordersOligonucleotidesGene Therapy
37
10/2010St. Louis UniversityUltragenyx Pharmaceutical$0.010$0.110Enzyme replacement therapy program to treat mucopolysaccharidosis type 7LicenseExclusivePreclinicalYesSEC RedactedEndocrinological & MetabolicLysosomal Storage DisordersWorldwide
38
8/2010Salk InstituteAcceleron$0.350$3.000Activin (ACTRII soluble receptors) to treat muscle wastingLicense, ResearchExclusiveLead MoleculeYesSEC FullEndocrinological & MetabolicOther Endocrinological & MetabolicRecombinant DNAWorldwide
39
6/2010BaylorBellicum Pharmaceuticals$0.030$0.030Methods f generating immune response by_x000D_
inducing CD40 and pattern recognition receptors		Development, LicenseExclusivePreclinicalYesSEC RedactedAutoimmune/InflammatoryBroad Focus Autoimmune/InflammatoryDiagnostics, PeptidesWorldwide
40
6/2010Scripps Research InstitutePoniard Pharmaceuticals, Allozyne$0.070$2.000Click chemistry for bioconjugationEquity, LicenseExclusiveDiscoveryYesSEC RedactedUnlimitedSyntheticsCombinatorialWorldwide
41
4/2010Dartmouth CollegeCelyad, Celdara Medical$0.020$1.520Chimeric NKG2D receptor-based T cell therapiesLicenseExclusivePreclinicalYesSEC FullCancerWorldwide
42
1/2010Scripps Research InstituteSorrento Therapeutics$0.010$1.760antibodies and vaccines for infectious diseaseDevelopment, Equity, LicenseExclusiveDiscoveryYesFOIAInfectious-BacterialMonoclonals, VaccinesHumanized Abs
43
11/2009City of HopeJuno Therapeutics, Zeta Acquisition$0.025CAR constructs for genetically engineered white blood cellsLicenseExclusiveLead MoleculeYesSEC RedactedUnlimitedCell Therapy - Stem Cells/FactorsWorldwide
44
10/2009Dana-FarberTransgenomic$0.220$0.390Methods of mutation detectionDevelopment, LicenseNon-exclusiveDiagnosticYesSEC FullDiagnosticsDNA ProbesWorldwide
45
10/2009XomaKaketsuken$8.000$8.200XOMA020 antibody phage display libraryLicenseSemi-exclusiveDiscoveryYesFOIAUnlimitedMonoclonalsWorldwide
46
6/2009Mayo Foundation, Mayo ClinicExact Sciences$0.080$1.330Non-invasive DNA screening diagnostic tests for colorectal cancerDevelopment, LicenseExclusiveDiagnosticYesSEC RedactedCancerColorectalDiagnosticsWorldwide
47
5/2009University of MinnesotaCelladon$0.240$0.240Small molecule compounds that modulate SERCA activity for cardio diseasesLicenseExclusiveLead MoleculeYesSEC RedactedCardiovascularBroad Focus CardiovascularScreeningWorldwide
48
4/2009Bristol-Myers Squibb, University of Massachusetts, Medarex, MassBiologicsMerck$60.000$225.000CDA-1 and CDB-1 mAb combination for Clostridium difficile infectionDevelopment, LicenseExclusivePhase IIPress ReleaseInfectious-BacterialOther Infectious-BacterialMonoclonalsHuman AbsWorldwide
49
4/2009NIHMRI Interventions$0.038$0.190Devices and systems for MRI-guided medical proceduresDevelopment, LicenseNon-exclusiveYesSEC RedactedDevice, DiagnosticsAsia, Europe, Middle East, NAFTAAll European Countries, Australia, Canada, China, Israel, Japan, US
50
3/2009Indiana UniversityCellular Dynamics International$0.100$4.100Myocardial graftsDevelopment, LicenseExclusivePreclinicalYesFOIACardiovascularMyocardial InfarctionCell Therapy - Stem Cells/FactorsWorldwide
51
2/2009Johns HopkinsBind Therapeutics$0.030$1.000Nanoparticles targeting PSMA for prostate cancer treatmentLicenseExclusiveLead MoleculeYesSEC RedactedCancerProstateSyntheticsSmall MoleculeWorldwide
52
12/2008Ottawa Hospital Research InstituteFate Therapeutics, Verio Therapeutics$0.060Wnt7a and analogs for treatment of muscle degenerationEquity, LicenseExclusiveLead MoleculeYesSEC Redacted
Endocrinological & Metabolic, Hematologic, Other/Miscellaneous
Broad Focus Hematologic, Genetic Disorders, Lysosomal Storage DisordersCell Therapy - Stem Cells/FactorsWorldwide
53
12/2008University of Tennessee Research FoundationProThera Biologics, Elan$0.080$0.080Novel therapeutics for treatment and prophylaxis of AmyloidosisLicenseExclusiveYesSEC FullOther/MiscellaneousWorldwide
54
11/2008University of Western AustraliaSarepta Therapeutics$0.038$0.110Treatment of Duchenne MD using exon skipping oligonucleotide technologyAssignment, LicenseExclusiveLead MoleculeYesSEC FullOther/MiscellaneousGenetic DisordersOligonucleotides
55
7/2008St. Jude Children's Research HospitaluniQure, Amsterdam Molecular Therapeutics$0.010$0.010gene therapy for Hemophilia BDevelopment, LicenseExclusiveYesSEC RedactedHematologicHemophiliaOligonucleotidesGene TherapyWorldwide
56
7/2008UC San DiegoSynthetic Biologics, Epitope$0.137$11.490Novel immunotherapies for treatment of Rheumatoid ArthritisLicenseExclusivePreclinicalYesSEC FullAutoimmune/InflammatoryRheumatoid ArthritisPeptides, VaccinesWorldwide
57
7/2008University of MiamiHeat Biologics$0.150$0.400ImPACT technology as cancer vaccineEquity, LicenseExclusiveLead MoleculeYesSEC RedactedCancerBroad Focus CancerCell Therapy - Stem Cells/Factors, TransgenicsWorldwide
58
6/2008Johns HopkinsMRI Interventions$0.075$0.080Catheter-based MRI probesLicenseExclusiveDeviceYesSEC RedactedDeviceWorldwide
59
6/2008Mayo FoundationNile Therapeutics$0.285$49.790Natriuretic polypeptidesDevelopment, Equity, LicenseExclusivePhase IYesFOIACardiovascular, RenalPeptidesWorldwide
60
5/2008Johns Hopkins, Duke UniversityDuska Therapeutics$0.680$2.330Reactive Oxygen Generating enzyme and inhibitor with Nitric Oxide BioactivityDevelopment, Equity, LicenseExclusiveLead MoleculeYesFOIAWorldwide
61
5/2008Virginia Commonwealth UniversityOxygen Biotherapeutics$0.070$1.550Gas based wound and tissue therapeuticsDevelopment, Equity, LicenseExclusivePreclinicalYesSEC FullDermatologicWound HealingWorldwide
62
5/2008YaleKolltan Pharmaceuticals$0.050$0.350monoclonal antibodies targeting receptor tyrosine kinases for therapeuticsLicense, ResearchExclusiveYesSEC RedactedMonoclonalsHumanized AbsWorldwide
63
2/2008Buck InstituteNeurobiological Technologies$0.175$1.380Netrin-1 proteinDevelopment, License, ResearchExclusivePreclinicalYesFOIAWorldwide
64
2/2008Salk InstituteuniQure$0.065$0.070DNA promoter to enhance gene therapy for lipoprotein lipase deficiencyLicenseNon-exclusiveDiscoveryYesSEC RedactedOther/MiscellaneousGenetic DisordersOligonucleotidesGene TherapyWorldwide
65
1/2008Rockefeller UniversityRosetta Genomics$0.040$0.040microRNAs for research purposesLicenseNon-exclusiveReagentYesSEC RedactedOligonucleotidesRNAiWorldwide
66
1/2008Wisconsin Alumni Research FoundationBiotime$0.250$0.250human embryonic stem cellsLicense, OptionExclusiveYesSEC FullCell Therapy - Stem Cells/FactorsWorldwide
67
1/2008YedaHistogenics, ProChon$0.002$0.020Expression of heterologous proteinsDevelopment, LicenseExclusiveDiscoveryYesSEC RedactedUnlimitedRecombinant DNAWorldwide
68
12/2007MIT, VersitechArch Therapeutics$0.095$1.000Novel peptides to control surgical adhesionsLicenseExclusiveLead MoleculeYesSEC FullDermatologicWound HealingPeptidesWorldwide
69
11/2007Buck InstituteNeurobiological Technologies$0.175$34.810Fibroblast growth factor-2 for treatment of ischemia and Huntington's DiseaseDevelopment, License, ResearchExclusivePreclinicalYesFOIACardiovascular, Central Nervous SystemOther Cardiovascular, Other Central Nervous SystemWorldwide
70
11/2007Burnham InstituteBiotime$0.040$0.040Novel homing peptides for cell coatings capable of directing cells to specific organsLicenseExclusiveYesSEC FullCancer, DermatologicSolid Tumors, Wound HealingPeptidesWorldwide
71
11/2007University College LondonFortress Biotech, Coronado Biosciences$0.100$22.080Tumor restricted natural killer cells for therapeutic useDevelopment, LicenseExclusivePreclinicalYesFOIACancerSolid TumorsWorldwide
72
10/2007University of California, UC San DiegoRaptor Pharmaceuticals, Encode Pharmaceuticals$0.070$6.350enterically coated cysteamine for cystinosis, Huntington's, Batten's, schizophreniaDevelopment, LicenseExclusivePhase IIYesFOIA
Central Nervous System, Endocrinological & Metabolic, Psychiatric
Lysosomal Storage Disorders, Other Central Nervous System, SchizophreniaDrug DeliveryControlled Release, OralWorldwide
73
9/2007University of GeorgiaBristol-Myers Squibb, Inhibitex$0.750$32.550HIV integrase & HCV polymerase InhibitorsEquity, License, ResearchExclusivePreclinicalYesFOIAInfectious-ViralBroad Focus Infectious-Viral, Hepatitis C, Human Immunodeficiency Virus/HIVSyntheticsSmall MoleculeWorldwide
74
6/2007Mayo FoundationCelyad$12.769$17.140Stem cell based therapy for non-ischemic cardiomyopathic heart failureEquity, License, ResearchExclusiveYesSEC FullCardiovascularOther CardiovascularCell Therapy - Stem Cells/FactorsWorldwide
75
5/2007BaylorInovio Pharmaceuticals, VGX Animal Health$0.025$0.950novel therapeuticsDevelopment, LicenseExclusivePreclinicalYesSEC RedactedWorldwide
76
5/2007NIHuniQure$0.027$0.030AMT-010 for Lipoprotein Lipase Deficiency Type I and V deficiencyDevelopment, License, ResearchNon-exclusivePreclinicalYesSEC RedactedEndocrinological & MetabolicOther Endocrinological & MetabolicOligonucleotidesGene TherapyAsia, Europe, NAFTAAll European Countries, Australia, Canada, US
77
5/2007University of AlbertaCortex Pharmaceuticals$0.035$0.310Method of inhibiting respiratory depression using AMPAKINEsDevelopment, LicenseExclusivePhase IYesFOIARespiratoryOther RespiratoryWorldwide
78
4/2007Scripps Research InstituteRepligen$0.325$4.880novel therapeutics for Friedreich's ataxiaDevelopment, Equity, LicenseExclusivePhase IIYesFOIACentral Nervous SystemOther Central Nervous SystemWorldwide
79
4/2007University of PennsylvaniaInovio Pharmaceuticals, VGX Animal Health$1.300$3.800HIV, HPV, HCV vaccinesDevelopment, LicenseExclusivePhase IYesSEC RedactedInfectious-ViralHepatitis C, Human Immunodeficiency Virus/HIV, Influenza, Other Infectious-ViralVaccinesWorldwide
80
2/2007University of WashingtonGenMark Diagnostics$0.060$0.060Methods and compositions for predicting drug responsesLicenseNon-exclusiveYesFOIAWorldwide
81
2/2007Washington UniversityProlor Biotech$0.115$0.200Carboxy terminal peptide-extended proteins and N-terminal CTP extended pharmaceutical peptidesDevelopment, Equity, LicenseExclusivePhase IYesSEC FullPeptidesWorldwide
82
1/2007BaylorMedgenics$0.045$0.150Helper-Dependent Adenoviral Vectors for gene therapyDevelopment, LicenseNon-exclusiveDiscoveryYesSEC FullOligonucleotidesGene TherapyWorldwide
83
1/2007University of MassachusettsRXi Pharmaceuticals$0.083$3.820RNA Interference Agents for Therapeutic UseDevelopment, Equity, LicenseExclusivePhase IYesFOIA
Central Nervous System, Endocrinological & Metabolic
Amyotrophic Lateral Sclerosis, Diabetes, ObesityOligonucleotidesRNAiWorldwide
84
1/2007University of MassachusettsRXi Pharmaceuticals$0.035$3.700Gene silencing with siRNA containing mismatches to targetsDevelopment, LicenseExclusivePhase IYesFOIACentral Nervous SystemAmyotrophic Lateral SclerosisOligonucleotidesRNAiWorldwide
85
1/2007University of MassachusettsRXi Pharmaceuticals$0.030$0.340Microwave assisted method of synthesis of new cationic reagents for efficient drug deliveryDevelopment, Equity, LicenseNon-exclusiveYesFOIADrug DeliveryWorldwide
86
1/2007University of MassachusettsRXi Pharmaceuticals$0.145$4.470Therapeutic silencing of genes involved in cholesterol biosynthesis by chemically modified siRNADevelopment, Equity, LicenseExclusivePhase IYesFOIAEndocrinological & MetabolicBroad Focus Endocrinological & MetabolicOligonucleotidesRNAiWorldwide
87
1/2007University of South FloridaMIMEDX$0.225$0.430novel therapeutics in the field of polymerized collagen fibers for ligament repairDevelopment, Equity, LicenseExclusiveYesSEC FullOther/MiscellaneousCollagen matrixWorldwide
88
1/2007Wisconsin Alumni Research FoundationAdamis Pharmaceuticals, Colby Pharmaceuticals$0.025$0.650Chroman-derived anti-androgens for treatment of androgen mediated disordersDevelopment, Equity, LicenseExclusivePhase IYesSEC FullCancerProstateWorldwide
89
12/2006Johns HopkinsMRI Interventions$0.035$0.040MRI safety technologiesLicense, SublicenseExclusiveDeviceYesSEC RedactedDeviceWorldwide
90
12/2006MITCerulean$0.040Nanoparticles containing selected polymersEquity, LicenseExclusiveLead MoleculeYesSEC RedactedSyntheticsPolymersWorldwide
91
12/2006University of WashingtonAchaogen$0.100$3.350ACHN-975 ( LpxC inhibitor) antibacterial compoundsEquity, LicenseExclusiveLead MoleculeYesSEC RedactedInfectious-BacterialBroad Focus Infectious-BacterialWorldwide
92
9/2006Duke UniversityCelldex$0.675$2.790vaccines and antibodies for glioblastoma multiforme and brain cancersEquity, License, ResearchExclusiveYesFOIACancerBrainMonoclonals, VaccinesHumanized AbsWorldwide
93
9/2006Johns HopkinsRosetta Genomics$0.125$0.400Novel miRNAsDevelopment, LicenseExclusiveLead MoleculeYesFOIAOligonucleotidesRNAiWorldwide
94
8/2006Johns HopkinsRosetta Genomics$0.125$0.130Human miRNAs and Their Evaluation with a Dicer KOLicenseNon-exclusiveYesSEC RedactedWorldwide
95
8/2006University of IllinoisOpko Health$0.250$2.250Novel therapuetics for treatment of ophthalmic diseasesDevelopment, LicenseExclusivePreclinicalYesSEC FullOphthalmicBroad Focus OphthalmicWorldwide
96
6/2006Max Planck InstituteRosetta Genomics$0.302$0.300Small expressed RNA moleculesLicenseSemi-exclusiveYesFOIAOligonucleotidesWorldwide
97
6/2006University of PennsylvaniaNuPathe$0.170$2.820LAD(TM) long acting delivery technology for neurologic and psychiatric disordersLicenseExclusivePhase IYesFOIACentral Nervous System, PsychiatricBroad Focus Central Nervous System, Broad Focus Psychiatric, Parkinson's Disease, SchizophreniaDrug DeliverySustained ReleaseWorldwide
98
5/2006Children's Hospital BostonAlseres Pharmaceuticals$0.010$0.790Use of inosine and other molecules for treatment of Central and Peripheral Nervous System diseasesDevelopment, License, Option, ResearchExclusivePreclinicalYesFOIACentral Nervous SystemBroad Focus Central Nervous System, Other Central Nervous System, Spinal Cord Injury, StrokeWorldwide
99
5/2006Rockefeller UniversityRosetta Genomics$0.100$0.100Micro RNA sequences for analyte specific reagentsLicenseSemi-exclusiveDiagnostic, ReagentYesFOIADiagnostics, OligonucleotidesDNA Probes, RNAiWorldwide
100
5/2006University of MassachusettsRXi Pharmaceuticals, CytRx$0.100$2.250siRNA for treatment of diabetes, obesity, ALS, and human cytomegalovirus (HCMV)Development, Equity, LicenseSemi-exclusivePreclinicalYesFOIA
Central Nervous System, Endocrinological & Metabolic, Infectious-Viral
Amyotrophic Lateral Sclerosis, Cytomegalovirus/CMV, DiabetesOligonucleotidesRNAiWorldwide